• Beverly Wilshire swung to a third-quarter FY26 loss attributable to equity holders of SGD 183,000 from a year-earlier profit of SGD 29,000.
• Revenue fell 51% year over year to SGD 1.28 million, reflecting weaker contributions from the aesthetic medical and healthcare segment.
• Other income rose 90% to SGD 288,000, mainly due to the write-back of amounts owed to a deregistered creditor.
• Operating activities used SGD 258,000 in cash, versus SGD 261,000 generated a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beverly Wilshire Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: VVXCBV9VSLUPXDC2) on November 11, 2026, and is solely responsible for the information contained therein.